BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29176838)

  • 21. Differential roles for group 1 mGluR subtypes in induction and expression of chemically induced hippocampal long-term depression.
    Volk LJ; Daly CA; Huber KM
    J Neurophysiol; 2006 Apr; 95(4):2427-38. PubMed ID: 16421200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP.
    Aguirre JA; Kehr J; Yoshitake T; Liu FL; Rivera A; Fernandez-Espinola S; Andbjer B; Leo G; Medhurst AD; Agnati LF; Fuxe K
    Brain Res; 2005 Feb; 1033(2):216-20. PubMed ID: 15694927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of group I metabotropic glutamate receptors, mGluR1/mGluR5, in connexin43 phosphorylation and inhibition of gap junctional intercellular communication in H9c2 cardiomyoblast cells.
    Xie F; Yi SL; Hao L; Zhang Y; Zhong JQ
    Mol Cell Biochem; 2015 Feb; 400(1-2):213-22. PubMed ID: 25421413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus.
    Sun YG; Rupprecht V; Zhou L; Dasgupta R; Seibt F; Beierlein M
    J Neurosci; 2016 Jul; 36(30):7886-96. PubMed ID: 27466334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
    Lea PM; Faden AI
    CNS Drug Rev; 2006; 12(2):149-66. PubMed ID: 16958988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
    O'Leary DM; Movsesyan V; Vicini S; Faden AI
    Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
    Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of NMDA receptors reduces metabotropic glutamate receptor-induced long-term depression in the nucleus accumbens via a CaMKII-dependent mechanism.
    Huang CC; Hsu KS
    Neuropharmacology; 2012 Dec; 63(8):1298-307. PubMed ID: 22947307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function.
    Mannaioni G; Marino MJ; Valenti O; Traynelis SF; Conn PJ
    J Neurosci; 2001 Aug; 21(16):5925-34. PubMed ID: 11487615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
    Bao WL; Williams AJ; Faden AI; Tortella FC
    Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations.
    Daniels M; Cereghetti GM; Brown DR
    Eur J Biochem; 2001 Dec; 268(23):6155-64. PubMed ID: 11733010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of group I metabotropic glutamate receptor subtypes involved in the frequency of epileptiform activity in vitro using mGluR1 and mGluR5 mutant mice.
    Stoop R; Conquet F; Pralong E
    Neuropharmacology; 2003 Feb; 44(2):157-62. PubMed ID: 12623213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices.
    Lee AC; Wong RK; Chuang SC; Shin HS; Bianchi R
    J Neurophysiol; 2002 Oct; 88(4):1625-33. PubMed ID: 12364493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion protein protects mice from lethal infection with influenza A viruses.
    Chida J; Hara H; Yano M; Uchiyama K; Das NR; Takahashi E; Miyata H; Tomioka Y; Ito T; Kido H; Sakaguchi S
    PLoS Pathog; 2018 May; 14(5):e1007049. PubMed ID: 29723291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo metabotropic glutamate receptor 5 (mGluR5) antagonism prevents cocaine-induced disruption of postsynaptically maintained mGluR5-dependent long-term depression.
    Grueter BA; McElligott ZA; Robison AJ; Mathews GC; Winder DG
    J Neurosci; 2008 Sep; 28(37):9261-70. PubMed ID: 18784306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Group I Metabotropic Glutamate Receptors Reverses Autistic-Like Phenotypes Caused by Deficiency of the Translation Repressor eIF4E Binding Protein 2.
    Aguilar-Valles A; Matta-Camacho E; Khoutorsky A; Gkogkas C; Nader K; Lacaille JC; Sonenberg N
    J Neurosci; 2015 Aug; 35(31):11125-32. PubMed ID: 26245973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro.
    Chen A; Hu WW; Jiang XL; Potegal M; Li H
    Psychopharmacology (Berl); 2017 Feb; 234(4):681-694. PubMed ID: 28028604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats.
    Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG
    Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.